Escitalopram in Preschool-Age Children Diagnosed with Obsessive Compulsive Disorder: A Case Report
When a literature review on pediatric obsessive-compulsive disorder (OCD) is performed, it is observed that there is a dearth of research on preschool period OCD cases. Although cognitive behavioral therapy is recommended as the first line of treatment in preschool OCD cases when patients do not show adequate response to CBT, psychopharmacological treatment offers an alternative. The first line used in psychopharmacological treatment is selective serotonin reuptake inhibitors (SSRI’s). However, no SSRI’s (or any other drug group) have been approved by the FDA for this age group. Moreover, studies related to psychopharmacology in preschool OCD are very limited in the literature, consisting mostly of case reports related to sertraline and fluoxetine. In those studies, it is reported that sertraline and fluoxetine are effective in preschool OCD and generally well-tolerated. In this paper, we discussed the treatment and six-month follow-up period of a 3.5 year-old (42 months) female diagnosed with OCD and for whom escitalopram was used. In the literature, there is a retrospective case series related to this subject consisting of eleven cases, where improvement in symptoms is reported with escitalopram treatment in the five of six cases diagnosed with OCD. As far as we could find in literature, our paper is the second report on this subject. Our case also included the youngest patient to receive escitalopram for preschool period OCD and report its benefits.
Jenike MA. Clinical practice. Obsessive-compulsive disorder. N Engl J Med 2004; 35: 259-265.
Heyman I, Mataix–Cols D, Fineberg NA. Obsessive-compulsive disorder. BMJ 2006; 333: 424-429.
Gleason MM, Egger HL, Emslie GJ, Greenhill LL, Kowatch RA, Lieberman AF, et al. Psychopharmacological treatment for very young children: contexts and guidelines. J Am Acad Child Adolesc Psychiatry 2007; 46: 1532-1572.
Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997; 36: 844-852.
Oner O, Oner P. Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports. J Psychopharmacol 2008; 22: 809-811.
Coskun M, Zoroglu S. Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2009; 19: 297- 300.
Coskun M, Ozturk M, Zoroglu S. Escitalopram treatment in preschool children with anxiety disorders: a case series. Bulletin of Clinical Psychopharmacology 2012; 22: 262-267.
Ercan ES, Kandulu R, Akyol Ardic U. Preschool children with obsessive- compulsive disorder and fluoxetine treatment. Eur Child Adolesc Psychiatry 2012; 21: 169-172.
Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive- compulsive disorder. Am J Psychiatry 2003; 160: 1919-1928.
Zuckerman ML, Vaughan BL, Whitney J, Dodds A, Yakhkind A, MacMillan C, et al. Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review. J Child Adolesc Psychopharmacol 2007; 17: 165-174.
Taylor S. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin Psychol Rev 2011; 31: 1083-1100.
Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 400-412.